← Browse by Condition
Medical Condition
adjuvant therapy
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT06344156 Phase 1
Recruiting
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
Enrollment
43 pts
Location
China
Sponsor
Sichuan University
NCT06056336 Phase 2
Recruiting
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Enrollment
73 pts
Location
China
Sponsor
Guo Xufeng
NCT06581315
Recruiting
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
Enrollment
204 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...